In the same study, it was shown that PI3K-Akt signal pathway mutations were more frequent in the HER2-low group, and checkpoint factors, Fanconi anemia, p53 signaling, and cell cycle pathway mutations were more frequent in the HER2-zero group. The gene discussed is TP53; the disease is Fanconi anemia.